Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Diabetic HFpEF
NCT06080802Phase 3Unknown
- Sponsor
- October University for Modern Sciences and Arts
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of metformin in heart failure with preserved ejection fraction (HFpEF), sponsored by October University for Modern Sciences and Arts. Status: unknown.
02
Drugs
metformin
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT06080802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06080802.